Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1998
08/11/1998US5792744 Proteins from mammalian liver
08/11/1998US5792743 Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
08/11/1998US5792742 Fibrin-binding peptide fragments of fibronectin
08/11/1998US5792669 Synthetic peptide and its uses
08/11/1998US5792656 Methods of preparing genetically engineered cells that produce insulin in response to glucose
08/11/1998US5792648 Isolated, purified polynucleotide sequence encoding polypeptide having specified amino acid sequence
08/11/1998US5792644 DNA encoding an Eimeria 200 kd antigen
08/11/1998US5792639 Paraoxonase polypeptides and use therefor
08/11/1998US5792638 Genetic engineering
08/11/1998US5792634 RNA polymerase transcription factor
08/11/1998US5792629 Nucleotide and amino acid sequences
08/11/1998US5792628 Secreted protein, BA3.1, and polynucleotides encoding same
08/11/1998US5792626 Human interferon-inducible protein
08/11/1998US5792624 Dirofilaria and onchocerca larval L3 cysteine protease proteins and uses thereof
08/11/1998US5792616 Antibodies to human cripto protein
08/11/1998US5792506 Disulfide bonds are reduced to sulfhydryl decreasing allergenicity of feeds
08/11/1998US5792463 Hybrid particle immunogens
08/11/1998US5792462 Alphavirus RNA replicon systems
08/11/1998US5792460 Modified glycoprotein hormones having a CTP at the amino terminus
08/11/1998US5792459 HIV-1 envelope muteins lacking hypervariable domains
08/11/1998US5792458 Selectively killing tumor cells
08/11/1998US5792457 Antibody recognizing endothelial cell ligand for leukocyte CR3
08/11/1998US5792456 Mutant BR96 antibodies reactive with human carcinomas
08/11/1998US5792453 Transfecting cells in coronary arteries by injection of a transgene-inserted replication-deficit adenovirus; antiischemic agents; cardiotonic agents; vascular disease
08/11/1998US5792450 Purified human CSF-1
08/11/1998CA2217321A1 Polymers incorporating peptides
08/11/1998CA1339997C Peptides for circulatory system control
08/11/1998CA1339992C Anticoagulant polypeptede
08/10/1998CA2223008A1 Def1
08/10/1998CA2222998A1 Def2
08/07/1998CA2222987A1 Novel compounds
08/07/1998CA2222984A1 Novel rat
08/07/1998CA2222978A1 Novel compounds
08/07/1998CA2222961A1 Novel compounds
08/06/1998WO1998034121A2 Isolated p27 protein and methods for its production and use
08/06/1998WO1998034120A1 Protein fragment complementation assays to detect biomolecular interactions
08/06/1998WO1998033942A1 Diagnosis and treatment of myocardial failure
08/06/1998WO1998033937A2 GENOMIC SEQUENCE OF THE HUMAN ν-OPIOID RECEPTOR GENE AND THE VARIANTS, POLYMORPHISMS AND MUTATIONS THEREOF
08/06/1998WO1998033929A2 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998WO1998033928A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector
08/06/1998WO1998033926A1 Reagents and methods useful for detecting diseases of the lung
08/06/1998WO1998033923A1 MUTANT msbB or htrB GENES
08/06/1998WO1998033922A1 The neurotrophic factor nnt-1
08/06/1998WO1998033921A1 Novel human cystatin-like protein
08/06/1998WO1998033920A2 Tissue factor pathway inhibitor-3
08/06/1998WO1998033918A1 Morphogenic proteins
08/06/1998WO1998033917A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033915A1 Breast cancer specific gene 1
08/06/1998WO1998033914A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998WO1998033913A1 Human integral membrane protein
08/06/1998WO1998033912A1 MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE
08/06/1998WO1998033911A1 Human signal transduction protein regulating the nuclear movement
08/06/1998WO1998033910A1 Novel proline-rich membrane protein
08/06/1998WO1998033909A1 Novel human atpase inhibitor protein
08/06/1998WO1998033908A1 Human c5a-like receptor
08/06/1998WO1998033907A1 A tumor suppressor designated ts10q23.3
08/06/1998WO1998033906A1 Insecticidal gene and peptide
08/06/1998WO1998033905A1 K-atp channels, materials and methods relating to cell membrane proteins
08/06/1998WO1998033896A2 Microorganisms with increased production of clavulanic acid
08/06/1998WO1998033892A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033887A1 Growth differentiation factor-8
08/06/1998WO1998033884A1 Renibacterium salmoninarum vaccine
08/06/1998WO1998033883A1 Regulators of apoptosis
08/06/1998WO1998033820A1 Method of chromatographically purifying or fractionating von willebrand factor from a vwf-containing starter material
08/06/1998WO1998033819A1 Cellular receptors for subgroup c adenoviruses and group b coxsackieviruses
08/06/1998WO1998033818A1 Human anion channel
08/06/1998WO1998033817A1 Human membrane protein
08/06/1998WO1998033816A1 Nucleic acid encoding an acetyl-coenzyme-a transporter protein
08/06/1998WO1998033815A1 Amyloid beta protein (globular assembly and uses thereof)
08/06/1998WO1998033814A1 THE 74 KILODALTON OUTER MEMBRANE PROTEIN FROM $i(MORAXELLA CATARRHALIS)
08/06/1998WO1998033812A1 Mast cell protease peptide inhibitors
08/06/1998WO1998033811A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998WO1998033810A2 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor
08/06/1998WO1998033533A1 A stabilized mixture comprising fibrinogen
08/06/1998WO1998033523A1 Vaccination methods and molecules
08/06/1998WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof
08/06/1998WO1998033511A1 Structurally modified peptides resistant to peptidase degradation
08/06/1998WO1998033510A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998WO1998033386A1 Method of delivering antigens for vaccination with a live vector
08/06/1998WO1998027116A3 Protein binding fragments of gravin
08/06/1998WO1998027113A3 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
08/06/1998WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents
08/06/1998WO1998024813A3 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998021332A3 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998020034A3 Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof
08/06/1998WO1998019703A3 Pharmaceutical antigen-antibody preparation
08/06/1998WO1998016645A3 Compounds and methods for diagnosis of tuberculosis
08/06/1998WO1998010794A3 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/06/1998WO1998006048A3 Molecular modelling of neurotrophin-receptor binding
08/06/1998WO1998005682A3 Peptides corresponding or imitating at least one antigenic determinant of the hamagglutinin protein of mobillivirus
08/06/1998WO1998001462A3 Urogenital carcinoma TLP complex peptides and antibodies thereof
08/06/1998DE19703801A1 New aza-bi:cyclic carboxylate ester di:peptide analogues
08/06/1998CA2282269A1 Diagnostic methods and compositions based on the distribution of rad51
08/06/1998CA2280229A1 Breast cancer specific gene 1
08/06/1998CA2279991A1 Human anion channel
08/06/1998CA2279579A1 Insecticidal gene and peptide
1 ... 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 ... 2916